Target Name: SNX4
NCBI ID: G8723
Review Report on SNX4 Target / Biomarker Content of Review Report on SNX4 Target / Biomarker
SNX4
Other Name(s): Sorting nexin 4 | SNX4_HUMAN | sorting nexin 4 | Sorting nexin-4 | SNX4 variant 1 | Sorting nexin 4, transcript variant 1 | ATG24B

SNX4: A Protein Involved in Tissue Development and Maintenance

SNX4, or Sorting nexin 4, is a protein that is expressed in various tissues throughout the body. It is a member of the superfamily of coiled-coil proteins, which are characterized by the presence of a coiled-coil region that can interact with other proteins. One of the unique features of SNX4 is its ability to interact with the protein ZNF2, which is known to play a role in the development and maintenance of tissues.

SNX4 has been shown to be involved in a number of physiological processes in the body, including cell signaling, tissue structure, and cellular processes that are important for the development and maintenance of tissues. It is also of interest as a potential drug target, due to its involvement in a number of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

One of the key functions of SNX4 is its role in the development and maintenance of tissues. SNX4 is a member of the superfamily of coiled-coil proteins, which are characterized by the presence of a coiled-coil region that can interact with other proteins. This interaction between SNX4 and other proteins allows it to play a role in the development and maintenance of tissues.

For example, SNX4 has been shown to be involved in the development and maintenance of tissues that are important for the development of organs, such as hearts and kidneys. Studies have shown that SNX4 is involved in the regulation of cell proliferation and differentiation, as well as the formation of tissues that are important for the development of organs.

In addition to its role in tissue development, SNX4 is also involved in the regulation of cellular processes that are important for the maintenance of tissues. For example, studies have shown that SNX4 is involved in the regulation of cell signaling, as well as the production of cellular organelles, such as mitochondria and endoplasmic reticulum.

SNX4 is also of interest as a potential drug target, due to its involvement in a number of diseases, including cancer, neurodegenerative diseases, and developmental disorders. For example, studies have shown that SNX4 is involved in the development and progression of cancer, and that it is a potential target for anti-cancer drugs. In addition, SNX4 is also involved in the development of neurodegenerative diseases, such as Alzheimer's disease, and has been shown to play a role in the regulation of cellular processes that are important for the maintenance of these diseases.

In conclusion, SNX4 is a protein that is involved in a number of physiological processes in the body, including cell signaling, tissue structure, and cellular processes that are important for the development and maintenance of tissues. It is also of interest as a potential drug target, due to its involvement in a number of diseases, including cancer, neurodegenerative diseases, and developmental disorders. Further research is needed to fully understand the role of SNX4 in these processes, as well as its potential as a drug target.

Protein Name: Sorting Nexin 4

Functions: Involved in the regulation of endocytosis and in several stages of intracellular trafficking (PubMed:12668730, PubMed:17994011, PubMed:32513819, PubMed:33468622). Plays a role in recycling endocytosed transferrin receptor and prevent its degradation (PubMed:17994011). Involved in autophagosome assembly by regulating trafficking and recycling of phospholipid scramblase ATG9A (PubMed:32513819, PubMed:33468622)

The "SNX4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNX4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SNX5 | SNX6 | SNX7 | SNX8 | SNX9 | SOAT1 | SOAT2 | SOBP | SOCAR | SOCS1 | SOCS2 | SOCS2-AS1 | SOCS3 | SOCS3-DT | SOCS4 | SOCS5 | SOCS5P5 | SOCS6 | SOCS7 | SOD1 | SOD2 | SOD2-OT1 | SOD3 | Sodium channel | Sodium-Glucose Cotransporter (SGLT) | Sodium-potassium-calcium exchanger | SOGA1 | SOGA3 | SOHLH1 | SOHLH2 | Soluble (cytosolic) protein tyrosine phosphatases | Soluble guanylyl cyclase | Solute Carrier Family 12 | Solute carrier family 29 member | Somatostatin receptor | SON | SORBS1 | SORBS2 | SORBS3 | SORCS1 | SORCS2 | SORCS3 | SORCS3-AS1 | SORD | SORD2P | SORL1 | SORT1 | Sorting and assembly machinery complex | Sorting nexin | SOS1 | SOS2 | SOSS complex | SOST | SOSTDC1 | SOWAHA | SOWAHB | SOWAHC | SOWAHD | SOX1 | SOX1-OT | SOX10 | SOX11 | SOX12 | SOX13 | SOX14 | SOX15 | SOX17 | SOX18 | SOX2 | SOX2-OT | SOX21 | SOX21-AS1 | SOX3 | SOX30 | SOX30P1 | SOX4 | SOX5 | SOX5-AS1 | SOX6 | SOX7 | SOX8 | SOX9 | SOX9-AS1 | SP1 | SP100 | SP110 | SP140 | SP140L | SP2 | SP2-AS1 | SP3 | SP3P | SP4 | SP5 | SP6 | SP7 | SP8 | SP9 | SPA17 | SPAAR